1-20 of 105
Jason R Westin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy

Rishika Prasad, Abdur Rehman, Lubna Rehman, Faezeh Darbaniyan, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, Eli Zamir, Sabine Schmidt, Tomo Hayase, Chang Chia-Chi, Lauren Kelley McDaniel, Ivonne Flores, Paolo Strati, Ranjit Nair, Dai Chihara, Luis E. Fayad, Sairah Ahmed, Swaminathan P. Iyer, Michael L Wang, Preetesh Jain, Loretta J. Nastoupil, Jason R Westin, Reetakshi Arora, Joel Gordon Turner, Fareed Khawaja, Ranran Wu, Jennifer B Dennison, Meghan Menges, Melanie Hidalgo-Vargas, Kayla M. Reid, Marco L. Davila, Peter Dreger, Felix Korell, Anita Schmitt, Mark R Tanner, Richard E. Champlin, Christopher R. Flowers, Elizabeth J Shpall, Samir Hanash, Sattva S. Neelapu, Michael Schmitt, Marion Subklewe, Johannes Fahrmann, Christoph Stein-Thoeringer, Eran Elinav, Michael D Jain, Eiko Hayase, Robert R Jenq, Neeraj Y Saini
Journal: Blood
Blood blood.2024025366.
https://doi.org/10.1182/blood.2024025366
Published: 2024
Includes: Supplemental data
Journal Articles

Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study

Michael R. Bishop, Michael Dickinson, Duncan Purtill, Pere Barba, Armando Santoro, Nada Hamad, Koji Kato, Anna Sureda, Richard Greil, Catherine Thieblemont, Franck Morschhauser, Martin Janz, Ian W. Flinn, Werner Rabitsch, Yok Lam Kwong, Marie José Kersten, Monique C. Minnema, Harald Holte, Esther Hian Li Chan, Joaquin Martinez-Lopez, Antonia MS Mueller, Richard T. Maziarz, Joseph P. McGuirk, Emmanuel Bachy, Steven Le Gouill, Martin Dreyling, Hideo Harigae, David A. Bond, Charalambos Andreadis, Peter A. McSweeney, Mohamed A. Kharfan-Dabaja, Simon Newsome, Evgeny Degtyarev, Chris Del Corral, Giovanna Andreola, Aisha Masood, Stephen J Schuster, Ulrich Jaeger, Peter Borchmann, Jason R. Westin
Journal: Blood
Blood (2021) 138 (Supplement 2): LBA-6.
https://doi.org/10.1182/blood-2021-155068
Published: 2021
Journal Articles

Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma Patients in Complete Metabolic Response at Time of Infusion

Sushanth Gouni, Jason R. Westin, Haleigh Mistry, Raphael Eric Steiner, Jinsu James, Simrit Parmar, Mansoor Noorani, Nathan H. Fowler, Sandra B. Horowitz, Lei Feng, Luis E. Fayad, Swaminathan P Iyer, Michael R Green, Misha Hawkins, Christopher R. Flowers, Sairah Ahmed, Loretta Nastoupil, Sattva S. Neelapu, Yago Nieto, Paolo Strati
Journal: Blood
Blood (2021) 138 (Supplement 1): 1740.
https://doi.org/10.1182/blood-2021-145503
Published: 2021
Journal Articles

Analysis of Factors Associated with Conversion to CR in Patients with Large B-Cell Lymphoma Achieving Day 30 PR after CAR T-Cell Therapy

Ajlan Al Zaki, Jason R. Westin, Grace Watson, Lei Feng, Sairah Ahmed, Haleigh Mistry, Loretta Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P Iyer, Hun Lee, Raphael E Steiner, Christopher R. Flowers, Elizabeth J. Shpall, Partow Kebriaei, Sattva S. Neelapu, Paolo Strati
Journal: Blood
Blood (2021) 138 (Supplement 1): 3870.
https://doi.org/10.1182/blood-2021-146023
Published: 2021
Journal Articles

Long-Term Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium

Jay Y. Spiegel, Michael D. Jain, Loretta Nastoupil, John Tamaresis, Armin Ghobadi, Yi Lin, Lazaros J. Lekakis, Patrick M. Reagan, Olalekan O. Oluwole, Joseph P. McGuirk, Abhinav Deol, Alison R. Sehgal, Andre H. Goy, Brian T. Hill, Charalambos Andreadis, Javier Muñoz, Matthew L. Ulrickson, Jason R. Westin, Julio C. Chavez, Miriam T. Jacobs, N Nora Bennani, Aaron P. Rapoport, Julie M. Vose, David B. Miklos, Sattva S. Neelapu, Frederick L. Locke, Saurabh Dahiya, Matthew A. Lunning
Journal: Blood
Blood (2021) 138 (Supplement 1): 3826.
https://doi.org/10.1182/blood-2021-147488
Published: 2021
Journal Articles

A Risk Score Incorporating Low Pass Whole Genome Sequencing of Cell Free DNA from Patients Receiving CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma

Hua-Jay J. Cherng, Ryan Sun, Haopeng Yang, Qing Deng, Luis Fayad, Nathan H. Fowler, Simrit Parmar, Sairah Ahmed, Raphael E Steiner, Fredrick B. Hagemeister, Hun Ju Lee, Ranjit Nair, Maria Alma Rodriguez, Felipe Samaniego, Swaminathan P Iyer, Loretta Nastoupil, Sattva S. Neelapu, Paolo Strati, Jason R. Westin, Michael R Green
Journal: Blood
Blood (2021) 138 (Supplement 1): 38.
https://doi.org/10.1182/blood-2021-148314
Published: 2021
Journal Articles

A Prospective Multicenter Study of Minimal Residual Disease Assessment Using a Next-Generation Immunosequencing Assay and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, Jason R. Westin, Stephen J. Schuster, Grzegorz S. Nowakowski, Izidore S. Lossos, Devin Copley, Clare Grieve, Allison P. Jacob, Ashlee Joseph, Leana Laraque, Gita Masand, Chelsea D Mullins, Ellen Napier, Tania Rodriguez, Venkatraman Seshan, Shreya Vemuri, Andrew D. Zelenetz
Journal: Blood
Blood (2021) 138 (Supplement 1): 52.
https://doi.org/10.1182/blood-2021-150572
Published: 2021
Journal Articles

Primary Analysis of ZUMA-7: A Phase 3 Randomized Trial of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Frederick L. Locke, David B. Miklos, Caron Jacobson, Miguel-Angel Perales, Marie José Kersten, Olalekan O. Oluwole, Armin Ghobadi, Aaron P. Rapoport, Joseph P. McGuirk, John M. Pagel, Javier Muñoz, Umar Farooq, Tom Van Meerten, Patrick M. Reagan, Anna Sureda, Ian W. Flinn, Peter Vandenberghe, Kevin Song, Michael Dickinson, Monique C. Minnema, Peter A. Riedell, Lori A. Leslie, Sridhar Chaganti, Yin Yang, Simone Filosto, Marco Schupp, Christina To, Paul Cheng, Leo I. Gordon, Jason R. Westin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2.
https://doi.org/10.1182/blood-2021-148039
Published: 2021
Journal Articles

Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma

Chelsea C. Pinnix, Bouthaina S. Dabaja, Jillian R. Gunther, Penny Fang, Susan Wu, Loretta Nastoupil, Paolo Strati, Ranjit Nair, Sairah Ahmed, Raphael E Steiner, Luis Malpica-Castillo, Dai Chihara, Preetesh Jain, Luis Fayad, Jason R. Westin, Sattva S. Neelapu, Maria Alma Rodriguez, Fredrick B. Hagemeister, Hun Ju Lee, Michael Wang, Felipe Samaniego, Nathan H. Fowler, Christopher R. Flowers, Lei Feng, Linda Chi, Bita Esmaeli
Journal: Blood
Blood (2021) 138 (Supplement 1): 3526.
https://doi.org/10.1182/blood-2021-154172
Published: 2021
Journal Articles

Ten Year Follow up of the MD Anderson Cancer Center Phase 2 Study of Rituximab in Combination with Lenalidomide (R2) for Patients with Low Tumor Burden Follicular Lymphoma

Dai Chihara, Loretta Nastoupil, Paolo Strati, Felipe Samaniego, Lei Feng, Maria Alma Rodriguez, Luis Fayad, Jason R. Westin, Fredrick B. Hagemeister, Michael Wang, Sattva S. Neelapu, Nathan H. Fowler
Journal: Blood
Blood (2021) 138 (Supplement 1): 3532.
https://doi.org/10.1182/blood-2021-149293
Published: 2021
Journal Articles

Pacific: A Phase II Study of Brentuximab Vedotin and Nivolumab Alone and then Combined with Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Patients with Untreated Primary Mediastinal Large B-Cell Lymphoma

Raphael E Steiner, Paolo Strati, Christopher R. Flowers, Sattva S. Neelapu, Michael R Green, Loretta Nastoupil, Fredrick B. Hagemeister, Lei Feng, Sairah Ahmed, Ranjit Nair, Luis Fayad, Hun Ju Lee, Maria Alma Rodriguez, Jason R. Westin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1408.
https://doi.org/10.1182/blood-2021-149616
Published: 2021
Journal Articles

Smart Stop: A Phase II Study of Lenalidomide, Tafasitamab, Rituximab, and Acalabrutinib Alone and with Chemotherapy in Patients with Newly Diagnosed DLBCL

Jason R. Westin, Raphael Steiner, Lei Feng, Paolo Strati, Christopher R. Flowers, Sattva S. Neelapu, Loretta Nastoupil, Dai Chihara, Fredrick B. Hagemeister, Sairah Ahmed, Ranjit Nair, Luis Fayad, Hun Ju Lee, Maria Alma Rodriguez, Eric Davis, Michael R Green
Journal: Blood
Blood (2021) 138 (Supplement 1): 3572.
https://doi.org/10.1182/blood-2021-148524
Published: 2021
Journal Articles

Outcome of Patients with T- Cell Histiocyte Rich B Cell Lymphoma: Single Institution Series

Ranjit Nair, Nafis Deen, Sairah Ahmed, Roberto N. Miranda, Nathan H. Fowler, Luis Fayad, Raphael E Steiner, Fredrick B. Hagemeister, Maria Alma Rodriguez, Hun Ju Lee, Paolo Strati, Luis Malpica-Castillo, Dai Chihara, Preetesh Jain, Jillian R. Gunther, Christopher R. Flowers, L. Jeffrey Medeiros, Yago Nieto, Jeremy L. Ramdial, Sattva S. Neelapu, Loretta Nastoupil, Michael R Green, Michael Wang, Francisco Vega, Lei Feng, Swaminathan Padmanabhan Iyer, Jason R. Westin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1448.
https://doi.org/10.1182/blood-2021-154035
Published: 2021
Journal Articles

Prognostic Value of Delta Lymphocyte Index (DLIx) in Patients with Large B-Cell Lymphoma (LBCL) Treated with Chimeric Antigen Receptor (CAR) T-Cell Therapy

Paolo Strati, MD, Haleigh Mistry, Brittany Pulsifer, Luis Fayad, Sairah Ahmed, MD, Hun Ju Lee, MD, Swami P. Iyer, MD, Ranjit Nair, MD, Loretta J. Nastoupil, MD, Simrit Parmar, MD, MSCI, Maria Alma Rodriguez, MD, Felipe Samaniego, MD, Raphael Eric Steiner, MD, Michael Wang, MD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Mansoor Noorani, Catherine M. Claussen, MS, Elizabeth J. Shpall, MD, Partow Kebriaei, MD, Chris R. Flowers, MD MS, Jason R. Westin, MD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-135846
Published: 2020
Journal Articles

Persistent Overall Response on Early PET/CT Scans during Salvage Therapy for Relapsed or Refractory DLBCL Predicts for Disease Specific Survival

Hua-Jay J Cherng, MD, Raphael E Steiner, MD, Luis Fayad, Paolo Strati, MD, Ranjit Nair, MD, F. B. B. Hagemeister, MD, Loretta J. Nastoupil, MD, Hun Ju Lee, MD, Sattva S. Neelapu, MD, Christopher Flowers, MDMS, Felipe Samaniego, MD, Maria Alma Rodriguez, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Jason R. Westin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-134203
Published: 2020
Journal Articles

Clinical Efficacy of Polatuzumab Vedotin in Patients with Relapsed/Refractory Large B-Cell Lymphoma after Standard of Care Axicabtagene Ciloleucel

Paolo Strati, MD, Grace Watson, Sandra B. Horowitz, Pharm.D., Ranjit Nair, MD, Maria Alma Rodriguez, MD, Raphael Eric Steiner, MD, Luis Fayad, Jason R. Westin, MD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-135835
Published: 2020
Journal Articles

Treatment and Outcome of Patients with Follicular Lymphoma Relapsed or Progressed after Frontline Lenalidomide and Rituximab

Paolo Strati, MD, Felipe Samaniego, MD, Mariana Gallardo, Mansoor Noorani, F. B. B. Hagemeister, MD, Jason R. Westin, MD, Hun Ju Lee, MD, Maria Alma Rodriguez, MD, Sattva S. Neelapu, MD, Jillian R. Gunther, MD PhD, Rashmi Kanagal-Shamanna, MD, Francisco Vega, MDPhD, Nathan H Fowler, MD, Chris R. Flowers, MD MS, Loretta J. Nastoupil, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-134120
Published: 2020
Journal Articles

Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Paolo Strati, MD, Sudhakar Tummala, Loretta J. Nastoupil, MD MSc, Jason R. Westin, MD, Luis Fayad, MD, Sairah Ahmed, MD, Nathan H. Fowler, MD, F. B. Hagemeister, MD, Hun Ju Lee, MD, Swaminathan P. Iyer, MD, Ranjit Nair, MD, Simrit Parmar, MBBS, Maria Alma Rodriguez, MD, Felipe Samaniego, MD, Raphael Eric Steiner, MD, Michael L. Wang, MD, Chelsea Camille Pinnix, MD PhD, Sherry Adkins, ANP, Catherine M. Claussen, MS, Charles Martinez, Misha Hawkins, Nicole Johnson, Shirley George, Sattva S Neelapu, MD, Linda Chi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 765.
https://doi.org/10.1182/blood-2019-125769
Published: 2019
Journal Articles

Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation

Yingjun Wang, Ken H. Young, MD PhD, Denái R. Milton, Celina Ledesma, Elias Jabbour, MD, Zijun Yidan Xu-Monette, PhD, Jeffrey J. Molldrem, Paolo Anderlini, Amin M. Alousi, MD, Qaiser Bashir, MBBS, May Daher, MD, Luis E. Fayad, MD, Swaminathan P. Iyer, MD, Partow Kebriaei, MD, David Marin, MD, Rohtesh S. Mehta, MD, Amanda L. Olson, MD, Uday Popat, MD, Felipe Samaniego, MD, Jason R. Westin, MD, Muzaffar H. Qazilbash, MD, Jin S Im, MD PhD, Gabriela Rondon, MD, Alison Gulbis, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2021.
https://doi.org/10.1182/blood-2019-126719
Published: 2019
Journal Articles

Comparative Review of 30 Day Non-Relapse Mortality (NRM) in B-Cell Lymphomas Associated with Anti-CD19 Chimeric Antigen Receptor T-Cells (CAR-T) from FDA Database, Clinical Studies, and MD Anderson

Ethan Burns, MD, Kartik Anand, MD, Jason R. Westin, MD, Sai Ravi Kiran Pingali, MD, Joe Ensor, PhD, Dahlia Sano, MD, Loretta J. Nastoupil, MD MSc, Hun Ju Lee, Yago Nieto, MD PhD, Issa F. Khouri, MD, Felipe Samaniego, MD, Simrit Parmar, MBBS, Michael Wang, MD, Misha Hawkins, Sherry Adkins, ANP, Luis E. Fayad, MD, Raphael E Steiner, MD, Ranjit Nair, MBBS,MD, Sairah Ahmed, MD, Nathan H. Fowler, MD, Sattva S Neelapu, MD, Swaminathan P. Iyer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1931.
https://doi.org/10.1182/blood-2019-131077
Published: 2019